Fighting Alzheimer's disease, a form of dementia which affects five million Americans and currently has no cure, is a steadily growing effort in the United States. Democratic White House front-runner Hillary Clinton unveiled a plan to battle Alzheimer's disease. She said that she would more than double federal funding for research and treatment of the disease.
Congress recently increased the federal research budget by $350 million, on top of the $586 million that the National Institutes of Health spent this past year.
But Clinton proposed raising that budget to $2 billion per year until 2025.
The Clinton campaign notes that some two-thirds of Alzheimer's patients are women, and that prevalence in elderly African-Americans is twice as high as in elderly whites.
Clinton said, "Investment is vital because the disease is already costing $200 billion per year in the United States and that figure will only grow with the country's aging population."
Rudolph Tanzi, a neurology professor at Harvard Medical School and chair of the Cure Alzheimer's Fund Research Consortium, said, "Our main bottleneck in this field has been funding. We are a budget-constrained, not a knowledge-constrained field."